Nyxoah


Nyxoah is a medical device company focused on the development and commercialization of a hypoglossal nerve stimulation (HGNS) therapy.

Employees

11-50

Links


Org chart

Olivier Taelman
Director & CEO
Collapse
An Moonen
General Counsel
Rémi Renard
VP, Marketing & Market Access
Dan Mans
VP, Clinical & Regulatory Affairs
Inge Vanwittenbergh
Global HR Director
Vanwittenbergh Inge
Global HR Director
John Landry
Chief Financial Officer
Scott Holstine
Chief Commercial Officer (cco)

Board & advisors

Robert Taub
Founder & Chairman
Kevin Rakin
Director